公开(公告)号：US20160024408A1

公开(公告)日：2016-01-28

申请号：US14765745

申请日：2014-02-04

Applicant: CONSIGLIO NAZIONALE DELLE RICERCHE

Inventor： Giovanni NICOLOSI ,  Carmelo DRAGO ,  Leonarda, Francesca LIOTTA ,  Valeria LA PAROLA ,  Maria, Luisa TESTA

IPC: C10L1/02 ,  B01J19/12 ,  C07C41/09 ,  B01J19/10 ,  C10L1/185 ,  C07C67/297

CPC classification number: C10L1/026 ,  B01J19/10 ,  B01J19/126 ,  B01J19/129 ,  C07C41/09 ,  C07C41/14 ,  C07C67/24 ,  C07C67/297 ,  C10L1/1852 ,  C10L2200/0254 ,  C10L2200/0476 ,  C10L2270/026 ,  C10L2290/34 ,  C10L2290/36 ,  C11C3/003 ,  Y02E50/13 ,  C07C69/24 ,  C07C69/52 ,  C07C43/13

Abstract: A process for the conversion of a feedstock containing one or more fatty acid triglycerides to a mixture containing one or more fatty acid alkyl esters and t-alkyl glycerols, including reacting the feedstock with a compound of formula (I): R—O—RI  (I) wherein:RI is an alkyl, alkenyl or alkynyl having 1-18 carbon atoms;R is H or a tertiary alkyl group, wherein the reaction takes place in the presence of an acid transesterification catalyst by irradiation with microwaves and/or ultrasound and/or radio waves.

Abstract translation: 将含有一种或多种脂肪酸甘油三酸酯的原料转化为含有一种或多种脂肪酸烷基酯和叔烷基甘油的混合物的方法，包括使原料与式（I）化合物反应：R-O-RI （I）其中：R 1是具有1-18个碳原子的烷基，烯基或炔基; R是H或叔烷基，其中反应在酸性酯交换催化剂的存在下通过用微波和/或超声和/或无线电波照射进行。

公开(公告)号：US20230372421A1

公开(公告)日：2023-11-23

申请号：US18030455

申请日：2021-10-12

Applicant: CONSIGLIO NAZIONALE DELLE RICERCHE ,  VERA SALUS RICERCA S.r.l.

Inventor： Laura SIRACUSA ,  Carmelo DRAGO ,  Giuseppe RUBERTO ,  Giovanni Mario PITARI

IPC: A61K36/185 ,  A61K31/365 ,  A61K31/366 ,  A61P35/00 ,  A61K45/06

CPC classification number: A61K36/185 ,  A61K31/365 ,  A61K31/366 ,  A61P35/00 ,  A61K45/06 ,  A61K2236/11 ,  A61K2236/15 ,  A61K2236/53 ,  A61K2236/333

Abstract: The present invention concerns an extract from pomegranate (Punica granatum L), specifically obtained from one or more immature pomegranate fruits. This extract is obtained through an extraction process including steps a)-d) as described in the text and it may contain gallotannins, ellagitannins, ellagic acid derivatives and granatins. Pharmaceutical and nutraceutical compositions and food supplements comprising this extract fall within the scope of the present invention as well as their use in various fields, more specifically for the treatment of tumors.